(Photo: http://photos.prnewswire.com/prnh/20131114/AQ16999-INFO)

Approximately 26 percent of the 18.8 million Americans diagnosed with diabetes follow an insulin regimen recommended by their healthcare provider in order to manage their conditionⁱ. Many people with diabetes are prescribed insulin, either because their bodies do not produce insulin or do not use insulin properly.ⁱⁱ

Abbott′s interactive infographic takes the user through a "day in the life" of an insulin-using patient, which can include a complex routine of regular blood glucose monitoring, counting and logging carbohydrates, and calculating and injecting precise doses of insulin.

To visit the interactive infographic visit http://www.abbott.com/insulin-using-patient.htm

About Abbott Diabetes Care

Abbott Diabetes Care, based in Alameda, Calif., is a leader in developing, manufacturing and marketing glucose monitoring systems designed to help people better manage their diabetes. Additional information about Abbott Diabetes Care may be found at www.abbottdiabetescare.com.

About Abbott

Abbott (NYSE: ABT) is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 70,000 people.

Visit Abbott at www.abbott.com and connect with us on Twitter at @AbbottNews.

ⁱ Treatment of Diabetes in the United States, 2007–2009 (National Health Interview Survey). 2011 National Diabetes Fact Sheet. Centers for Disease Control and Prevention.

ⁱⁱ http://www.diabetes.org/living-with-diabetes/treatment-and-care/medication/insulin/

SOURCE Abbott